Gland Pharma reports 7% rise in Q3 consolidated net profit

03 Feb 2025 Evaluate

Gland Pharma has reported results for third quarter ended December 31, 2024 (Q3FY25)

The company has reported 6.62% rise in net profit at Rs 295.12 crore for Q3FY25 as compared to Rs 276.81 crore for the same quarter in the previous year. However, total income of the company decreased by 5.73% at Rs 1075.85 crore for Q3FY25 as compared to Rs 1141.25 crore for the corresponding quarter previous year.

On consolidated basis, the company has reported 6.69% rise in its net profit at Rs 204.69 crore for the quarter ended December 31, 2024 as compared to Rs 191.86 crore for the same quarter in the previous year. However, total income of the company decreased by 8.85% at Rs 1442.55 crore for Q3FY25 as compared to Rs 1582.55 crore for the corresponding quarter previous year.

Gland Pharma Share Price

1408.85 -4.10 (-0.29%)
29-Apr-2025 10:43 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1818.25
Dr. Reddys Lab 1176.35
Cipla 1542.05
Lupin 2067.00
Zydus Lifesciences 885.20
View more..
© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.
×
Please wait your portfolio is updating...